Cargando…
Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism
Streptozotocin (STZ), a glucosamine-nitrosourea compound derived from soil bacteria and originally developed as an anticancer agent, in 1963 has been found to induce diabetes in experimental animals. Since then, systemic application of STZ became the most frequently studied experimental model of ins...
Autor principal: | Grieb, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789228/ https://www.ncbi.nlm.nih.gov/pubmed/25744568 http://dx.doi.org/10.1007/s12035-015-9132-3 |
Ejemplares similares
-
Performance of the intracerebroventricularly injected streptozotocin Alzheimer’s disease model in a translationally relevant, aged and experienced rat population
por: Gáspár, Attila, et al.
Publicado: (2022) -
Effect of intraperitoneal or intracerebroventricular injection of streptozotocin on learning and memory in mice
por: Zhang, Yang, et al.
Publicado: (2018) -
Treadmill running improves spatial learning and memory in the rats with intracerebroventricular injection of streptozotocin
por: Yosefi, Mahdieh, et al.
Publicado: (2011) -
Intracerebroventricularly Injected Streptozotocin Exerts Subtle Effects on the Cognitive Performance of Long-Evans Rats
por: Gáspár, Attila, et al.
Publicado: (2021) -
Folic Acid and Coenzyme Q10 Ameliorate Cognitive Dysfunction in the Rats with Intracerebroventricular Injection of Streptozotocin
por: Dehghani Dolatabadi, Hamid Reza, et al.
Publicado: (2012)